NCT01813383View on ClinicalTrials.gov

Clinical Relevance of Typing HLA-DR7-DQ2

CompletedOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

December 31, 2012

Study Completion Date

March 31, 2013

Conditions
Celiac Disease Patients Following Recommendations of ESPGHANHLA-DQ2 Typing Include HLA-DR7-DQ2 Haplotypes
Interventions
OTHER

There is not any intervention

Trial Locations (1)

08208

Corporació Sanitària i Universitària Parc Taulí, Sabadell

Sponsors
All Listed Sponsors
lead

Corporacion Parc Tauli

OTHER

NCT01813383 - Clinical Relevance of Typing HLA-DR7-DQ2 | Biotech Hunter | Biotech Hunter